Replying to:

The SFCE (French Society for children with Cancer) in collaboration with MGHI has just published the results of the metro-SFCE01 trial in Frontiers in Pharmacology. The article entitled "Paediatric metronomic four-drug metronomic regimen has anti-tumour activity in pediatric low-grade glioma; the results of a phase II clinical trial " authored by Arnauld Verschuur from the Pediatric hematology-oncology department, Assistance Publique Hôpitaux de Marseille, France and MGHI. This article (...)

pre-moderation

This forum is moderated beforehand: your contribution will only appear after being validated by a site administrator.